- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05590988
Sensorimotor Arm Rehabilitation After Stroke (TAB-APP)
November 4, 2022 updated by: BDH-Klinik Hessisch Oldendorf
Sensorimotor Arm Rehabilitation After Stroke Using Tablet-based Bimanual Coordination Training
Hemiparesis is a frequently observed symptom of stroke.
There are various therapy options that are used in the rehabilitation of patients.
Some studies have shown that, in addition to unilateral arm training, bilateral arm training can also lead to positive results in treatment and is a useful addition to therapy.
The newly developed app requires the coordination of both arms in certain time sequences and intensities or rhythms and addresses different sensory modalities (visual, auditory and kinesthetic).
The aim of the study is to examine whether tablet-based training improves bimanual coordination.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Simone B Schmidt, Dr.
- Phone Number: +49 5152 781 215
- Email: si.schmidt@nkho.de
Study Locations
-
-
Lower Saxony
-
Hessisch Oldendorf, Lower Saxony, Germany, 31840
- Recruiting
- Institute for Neurorehabilitation Research, BDH-Clinic Hessich Oldendorf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
36 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of an ischemic/hemorrhagic stroke
- moderate upper extremity paresis: 30 to 60 cubes in the Box-and-Block Test (BBT)
- sufficient resilience / alertness (active participation possible for at least 30 minutes)
- ability to give consent (written declaration of consent from the patient)
Exclusion Criteria:
- Hemianopia and/or neglect
- duration of illness >3 months
- pre-existing hemiparesis
- participation in another clinical trial within the last 30 days
- a pregnancy or breast-feeding period
- contraindications for MRI: claustrophobia; metallic or magnetic implants that contain iron, cobalt or nickel (e.g. pacemakers, brain pacemakers, automatic insulin pumps, electrodes, plates, clips, implanted hearing aids, dental implants, metal endoprostheses, metal parts or metal splinters in the body)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tablet
The intervention group trained bimanual coordination once a day for about 31 minutes on a total of ten days using a tablet game.
A ball is to be moved on a circular line.
|
Each task is performed for one minute, followed by a 2-minute break.
After the task has been performed three times, there is a 5-minute break.
The training block is then carried out twice more.
This means that three "blocks" are carried out for each therapy unit.
|
Active Comparator: Aximo
The patients in the control group receive an ergotherapeutic therapy unit once a day for the same length of time (approx.
31 minutes) for a total of ten days, in which they train unilaterally.
In this therapy unit, the control group uses the "Aximo".
This is a comb stand and so-called "rolls" with which plugging tasks can be practiced.
The patients should push the rolls into the stand fields with the affected hand.
With the plug-in game, the patients can complete different tasks that challenge and train their hand-eye coordination, their fine motor skills and their ability to grasp things (e.g.
following a specific pattern based on a template or putting colors in a specific order).
|
A task is performed for one minute at a time, followed by a 2-minute break.
Once three rounds have been completed, there is a 5-minute break.
As in the intervention group, there are a total of three training blocks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of the hand/arm motor skills (unilateral)
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference in moving wooden cubes in the Box-and-Block Test (BBT) The BBT measures unilateral gross manual dexterity.
The patient has to move as many individual cubes as possible from one side of the box over a partition to the other within one minute.
The test takes place in a seated position and is performed sequentially with the non-impaired hand and the affected hand.
The number of cubes transported for each side is evaluated.
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Changes in bimanual coordination 1
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference in moving wooden cubes in the modified Box-and-Block Test (mBBT) For this, a modified box with three compartments and two partitions is used.
The task is to take a cube in one hand, pass it to the other hand over the first partition and then transport it over the second partition to the outer compartment.
The dice are then counted in the outer compartment.
The dice that fall from one hand to the other in the middle compartment are counted separately.
The task is performed twice, starting with the unimpaired hand in the first run and with the impaired hand in the second run.
The subject has one minute per round to transport as many cubes as possible to the outer compartment.
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Changes in bimanual coordination 2
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference in activity index (calculated from acceleration, movement amplitude and movement frequency during the use of the tablet game)
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of functional abilities
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference of National Institutes of Health Stroke Scale (NIHSS)
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Change of activities of daily living
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference of Barthel-Index (BI)
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Change of hand strength
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Hand strength is measured with a KERN MAP digital hand force gauge.
The change of strength (in kg) is calculated.
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Change of selective motor control after a stroke
Time Frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
measured by the difference of the values of the "Fugl-Meyer-Test" (FMT)
|
Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of functional connectivity of the motor system
Time Frame: Pre-test (day 1), Post-test (day 18)
|
measured by differences between resting state functional magnetic resonance imaging (fMRI) scans
|
Pre-test (day 1), Post-test (day 18)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jens D Rollnik, Prof. Dr., BDH-Klinik Hessich Oldendorf
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2022
Primary Completion (Anticipated)
October 1, 2023
Study Completion (Anticipated)
March 1, 2024
Study Registration Dates
First Submitted
October 13, 2022
First Submitted That Met QC Criteria
October 19, 2022
First Posted (Actual)
October 21, 2022
Study Record Updates
Last Update Posted (Actual)
November 7, 2022
Last Update Submitted That Met QC Criteria
November 4, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TAB-APP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Tablet-based training
-
Universidade da MadeiraCasa de Saúde Câmara PestanaCompletedPsychiatric DisorderPortugal
-
Seoul National University Bundang HospitalInstitute of Information & Communications Technology Planning & Evaluation...CompletedMild Cognitive ImpairmentKorea, Republic of
-
Seoul National University HospitalSuspendedREM Sleep Behavior DisorderKorea, Republic of
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
Umeå UniversityKarlstad UniversityRecruitingParkinson Disease | Cognitive ImpairmentSweden
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
University Hospital, BonnCompleted
-
University of California, San FranciscoAkili Interactive Labs, Inc.CompletedMultiple Sclerosis | Cognitive DeclineUnited States
-
Brno University HospitalRecruitingLymphoma | Hematologic MalignancyCzechia
-
University of UtahTerminated